Conventional hearing aids are no longer the exclusive solution to patients with sensorineural hearing loss (SNHL). Middle ear implantable devices constitute a new viable option for hearing-impaired individuals. They can be used in cases where the conventional hearing aids are poorly tolerated such as in chronic external auditory canal inflammatory or infectious diseases. Conventional hearing aid technology historically experienced various drawbacks such as unsatisfactory sound quality (limited frequency range and undesired distortion), occlusion of the external ear canal, increased feedback with higher amplifications, and social stigma (1Y8). When middle ear implants were introduced, they had the advantage of avoiding ear canal occlusion, of being more cosmetically acceptable for the patients, and they offered an amplification of sound that is reportedly comparable to the traditional devices (4, 9, 10) .
In our center, we use 3 different types of middle ear implants, the semi-implantable Otologics MET implant (Otologics, Boulder, CO, USA), the fully implantable Carina implant (Otologics), and the Vibrant SoundBridge (VSB) (Vibrant Med-el, Innsbruck, Austria). The VSB was the first implant introduced on the market. It received the European CE mark in 1998 and was Food and Drug Administration approved in 2000 (11) . It consists of a surgically implanted vibrating ossicular prosthesis (VORP) that has an electromagnetic floating mass transducer coupled to the long process of the incus by titanium straps and of an externally worn audio processor that is held by a magnet to the implanted VORP. As for the Otologics implant, it was later introduced on the market, and the first operation using this implant was performed at our center in Copyright @ Otology & Neurotology, Inc. Unauthorized reproduction of this article is prohibited.
September 2005. This implant uses an electromechanical transducer that is fixed to the petrous bone and placed inside the atticotomy cavity. The tip of the transducer contacts and vibrates the body of the incus. This coupling may be achieved by performing a laser hole in the body of the incus in which the tip of the transducer is applied, or it can simply be done via careful transducer-incus body contact without the laser hole. The semi-implantable Otologics implant includes an externally worn audioprocessor that is fixed by magnets to the implanted part, whereas the fully implantable version has a subcutaneous microphone incorporated within the implantable part.
Several previous studies have discussed the functional audiologic gain obtained with these devices, as well as patient satisfaction with each particular implant separately (4, 7, 9, 10, 12, 13) . In a study by Snik and Cremers (14) , patients were satisfied with VSB use because it avoided the conventional ear canal itching caused by regular hearing aids, but there was no significant surplus audiologic value of the VSB. Using the Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire, other authors also found more patient satisfaction with the VSB (7, 9, 12) with greater improvement in speech discrimination scores compared with conventional hearing aids (7) . Patient satisfaction with the Otologics implant also has been assessed using the APHAB questionnaire and has been found to be comparable with conventional hearing aids (4) .
A point to keep in mind is that the maximal audiologic gain that can be offered by each implant_s technology is different from the actual gain that has to be adjusted according to each patient_s comfortable hearing level. In addition, although the patients_ functional gain might be satisfactory when tested in the audiologic booth and documented on the audiogram, the real-life situations offer additional auditory cues and challenges that might dilute this gain. Daily life patient satisfaction remains the real end point of every medical intervention. In this study, we will briefly discuss the audiologic results obtained with each implant and will then focus primarily at assessing the patients_ satisfaction with the 3 different kinds of middle ear implantable hearing aids.
PATIENTS AND METHODS
Between September 1998 and December 2008, we have implanted 112 patients with 3 different implantable hearing devices (Fig. 1 ). As these implants are CE marked (Communauté Européenne) for sale in Europe and used routinely for moderate to severe SNHL, no submission to an institutional review board was required for this study. However, all patients gave their written informed consent to be implanted with this device and for the specific indication of SNHL. For this study, we reviewed the medical charts and retrospectively gathered preimplantation and postimplantation audiologic data to evaluate the functional gains obtained with the implants. All audiograms were done by the same audiologist in the same sound-treated double walled audiologic booth. Preoperative and postoperative audiologic testing were done using sound field pure tones, with the contralateral nonoperated ear occluded and masked. The preoperative baseline audiograms of the operated side were done the day before surgery, and their means are shown in Figure 2 . Patients in the 3 groups exhibited a moderate-to-severe downsloping SNHL. This was symmetrical for both ears as seen from the pure tone average values (500, 1,000, 2,000, and 4,000 Hz) (Fig. 3) . There was no mixed hearing loss in any of the patients. The postoperative audiograms were done at 2 to 3 months at the time of implant activation and then at regular follow-up visits every 3 months and/or after any implant setting adjustments. Data analysis was performed using the most recent postoperative data with the optimal implant settings preferred by each patient. Functional gain was calculated as averaged free field between 500 and 4,000 Hz, unaided/aided. Bone conduction thresholds were obtained for all patients preoperatively and postoperatively, as well as the 50% speech reception thresholds (SRTs), which is the intensity threshold at which the patients were able to repeat 50% of the bisyllabic words presented to them.
To assess patient satisfaction with these implants, we have devised a specific questionnaire (Appendix A). We did not choose one of the already validated questionnaires because we found them to be too lengthy, sometimes inapplicable to implantable hearing aids, and lacking much information that we wanted to inquire about. Our questions focused on 3 major items: implant dysfunction problems, satisfaction with the implant_s sound amplification and sound quality, and common daily life implant applications that help evaluate the patient satisfaction with the implants practically. At the time of inclusion, all patients were consistent users of their implants and had sufficient experience so as to be considered well adapted to their devices. Our minimal implant follow-up period was 1 year.
Sixty-four of the 112 patients returned a completely filled questionnaire, with a response rate of 57%. Table 1 These numbers include 10 bilaterally implanted patients: Eight patients had bilateral VSB implants, 1 patient had a semiimplantable Otologics implant on one side and an Otologics Carina on the other, and another patient had an Otologics Carina on one side and a VSB on the other (Fig. 4) . In summary, there were a total of 64 patients with 74 implants.
We would like to note that it was not our aim to perform statistical comparison between the 3 groups. The 3 baseline patient populations are audiologically different, and each of the implants has different indications and limitations than the others depending on the degree of hearing loss severity (13) . Therefore, a comparison between the groups would not be correct. In addition, one limitation of this study is limited sampling of all 3 implants, which limits the power of any comparative statistical analysis.
RESULTS

Audiologic Results
The average postoperative follow-up was 5.1 T 2.2 years (range, 2Y8 yr) for Group I, 1.9 T 0.9 years (range, 1Y4 yr) for Group II, and 3.3 T 3.3 years (range, 1Y11 yr) for Group III. The unaided mean air conduction thresholds of all patients remained unchanged postoperatively with absence of air bone gaps, confirming the safety of the procedure and the absence of any significant loading on the ossicular chain (Fig. 5) . The functional gain in the 3 groups is shown in Figure 6 and detailed in Table 2 . The highest functional gain was for the Otologics semiimplantable group, followed by the other 2 groups. SRT improved by 28 T 7.9 dB in the semi-implantable Otologics implant group, 13 T 7.7 dB in the carina group, and 10 T 9.3 dB in the VSB group (Table 3) .
Patient Satisfaction
The audiologic functional gains are evident. However, these might not reflect the real benefit experienced in everyday use, and thus, we will refer to them as Bin situ[ results, as opposed to the Bin-vivo[ real-life conditions. We aimed in our article to study whether patients were practically feeling the gain from the implant in their daily life activities and whether the audiologic improvement is translated into patient satisfaction.
Implant Use and Dysfunction
Before assessing patient satisfaction, we first checked whether the patients had really been loyal users of their implants and whether these implants were functioning adequately. The patients from the 3 groups used their implants an average of 12 T 4 hours per day. Regarding battery charging or changing, 19% to 25% of patients in the 3 groups considered it as a burden, and this consisted of 1 change of batteries every 4.7 T 2.2 days for the semiimplantable Otologics implant group, a battery charging of 1 hour daily for the Carina group, and 1 change of batteries every 10.7 5. T 5.4 days for the VSB group.
As for implant function, 53% of the semi-implantable Otologics implant patients reported having had a dysfunction in the external transmitter coil, and 33% had misplaced or lost it at a certain point in time. Local skin irritation was present in 23% of the patients, and 47% reported intermittent pain at the site of the implant. Three patients underwent revision surgery for changing a dysfunctioning implant. In the Carina group, there was no significant local skin irritation because of the absence of an external device wear, and 12.5% of patients reported intermittent pain. There was no implant dysfunction. As for the VSB patients, 6% had a dysfunction in the external device, and one patient had lost it. Skin irritation at the site of the implant was reported in 23% of cases, and pain was present in 29%. Four patients underwent revision surgery for changing a dysfunctioning implant.
Audiologic Satisfaction
Regarding the audiologic satisfaction, 88% of Group I, 29% of Group II, and 72% of Group III patients were satisfied with their audiologic gain. Sound quality was reported as metallic in nature in 35%, 50%, and 60% in the 3 groups, respectively. Many patients complained of resonance of their voice, mostly in Group II (87% versus 53% and 26% for Groups I and III, respectively). Whistling and feedback of the implant also were reported in 62.5%, 37.5%, and 23% in Groups I, II, and III, respectively, and they occurred mainly with increasing device amplification. An alteration of hearing with altitude changes was reported by 3 semi-implantable Otologics patients, 2 Carina patients, and 7 VSB patients. Approximately 62.5% of Group I patients wore contralateral conventional digital hearing aids after the implantation. Of these patients, 58% were more satisfied with the behind-the-ear hearing aid compared with the implant, 17% reported equivalent gains, and 25% reported better hearing with the implant. Approximately 50% and 48% of patients in Groups II and III, respectively, had contralateral hearing aids. In the Carina group, 60% reported better hearing with the contralateral hearing aid, 20% better hearing with the implant, and 20% equivalent hearing in both ears, whereas in the VSB group, 29% reported better contralateral hearing with the hearing aid, 42% better hearing with the implant, and 29% equivalent hearing in both ears (Fig. 7) .
As for conversation intelligibility, we can see from Figure 8 that, with all 3 implants, the patients were, in general, satisfied in one-to-one conversations (89%, 72%, and 84% for Groups I, II, and III, respectively), but as the number of people and as the volume of background noise increased, the level of satisfaction dropped (Fig. 8) .
Furthermore, 87% of patients in Group I, 100% in Group II, and 69% in Group III reported feeling obliged to switch off their implants in certain crowded situations, namely restaurants, big malls, and other noisy environments, because they were bothered by the noise level.
As for multimedia activities such as watching movies in theaters and listening to music or to the radio, 57% of patients in the semi-implantable Otologics group were able to engage in these activities, and they rated their satisfaction as 75%, as opposed to 67% in the Carina group with 15% satisfaction, and 80% in the VSB group with 63% satisfaction.
Other Practical Considerations
Regarding the question whether the implants were practical during sports, all patients doing walking or jogging sports were satisfied in general with their implants whatever the type of implant; those exercising water or snow activities did not wear the implants (in case of the partially implantable ones) or were unsatisfied because of the noise of water friction (in case of the fully implantable Carina). The patients doing biking sports were bothered by the implant contact with their helmets in the case of the semiimplantable devices.
Seventy percent of the patients were retired, and thus, there was no significant effect of the implantation on their work activities. Of those who still worked, 25% reported a positive effect of the surgery on their work because of a relatively better interaction and intelligibility with clients and colleagues, and 5% reported a negative effect because of poor understanding in noisy environments or in conferences.
We also inquired in our questionnaire about some other miscellaneous events that could be a source of nuisance to our patients. Two patients from Group I, 2 from Group II, and 8 from Group III caused alarms to be activated when passing through mall or airport security gates. There were 5 and 14 patients in Groups I and III, but none from Group II, who reported interferences with electronic equipment such as radios, mobile phones, and microwaves. In addition, 2 to 3 patients in each group were bothered by being unable to undergo magnetic resonance imaging because of the presence of their implants, and this was substituted by a regular radiograph or a computed tomographic scan in most cases and a scintigraphy scan in 1 case. Other patient complaints included indiscretion of the large-sized external processor of the partially implantable devices. Finally, perhaps the best indication of patient satisfaction with the implant is willingness to undergo the surgery again. In the semi-implantable Otologics implant group, 55% of patients said they would undergo the surgery again, 12% might redo it, and 33% would not. In the Carina group, 29% would redo it, 14% might, and 57% would not. In the VSB group, 67% would redo the surgery, and 33% would not.
DISCUSSION
The technological developments in hearing aid technology, their miniaturization, and the patients_ wish to have more discrete devices have all led to the development of implantable hearing aids. These implants would help decrease the sound reflected from the tympanic membrane and thus decrease feedback, with elimination of the traditional occlusion effect. Our indications for using these implants included, at first, patients with SNHL who could not wear or did not benefit from the conventional hearing aids. Recently, we also have implanted patients with mixed hearing loss, but this is the subject of another ongoing study.
When they were first introduced on the market, several reports described an advantage of these implants over the conventional hearing aids (9, 10, 12) . However, for the past 10 years, the digital hearing aids have evolved tremendously, and this previous comparative advantage of the implants might no longer be as clear cut as previously described. We think that the technological shine that accompanied the birth of these implants and that appealed to both surgeons and patients has slowly faded with growing experience with the implants. Nonetheless, this does not negate the fact that they remain very beneficial for many individuals who have SNHL, and we have to be selective in recruiting our patients to get a good eventual outcome. We will first briefly discuss the objective audiologic results to move afterward in depth to our satisfaction questionnaires.
BIn Situ[ Audiologic Gain
The criteria for implanting each individual device have been elaborated at length in previous publications (9,11,13Y15) . Implant safety also has been established in several studies, with no statistically significant change in the unaided residual hearing between the preoperative and postoperative values, as also was the case in our study where unaided air conduction remained unchanged (4,9Y12,16) . Furthermore, there is a proven improvement in functional gain and SRT with these implants, as also seen in our cases (10, 12) . This was stable over time as shown by Mosnier et al. (17) in his VSB population. Our concern in this article was to see whether this gain was translated practically into patient satisfaction because the correlation between audiologic data and patient satisfaction is not always reliable (10) .
BIn Vivo[ Real-Life Patient Satisfaction
With the advancement in conventional hearing aid technology, the important point to consider when choosing between an implantable hearing aid and a traditional one remains ultimately the satisfaction and social integration that each offers to the patients. Because both can offer quite good amplification, we have to see which will be more convenient for daily use by the patients.
The patients in our 3 groups used their implants almost all day (12 h on average) for at least 1 year, which is our minimal follow-up period. This indicates sufficient experience with the implants and thus good reliability when assessing their satisfaction. Although patients might not be perfectly satisfied with the functional gain, the absence of ear canal itching, pain, or occlusion were compensatory (14) . Battery life was longest for the VSB group, and on average, 80% of patients in all groups did not think that changing or charging the battery constituted a burden in their daily lives. There was a relatively large number of external device dysfunction and loss problems in the semi-implantable Otologics implant group, mainly because the magnetic device got attracted to nearby metallic surfaces. Overall, our patients reported more device malfunction than the 0.03% reported rate in another study (10) . In cases where skin irritation was present (23%Y25%), the external processor was replaced with a weaker magnet processor, maintaining enough attachment strength to avoid inadvertent falling of the processor. In addition, local skin care was applied, and we advised the patients to temporarily decrease their wear of the implant until the skin has healed. There were 3 revision operations in the semi-implantable Otologics implant group for changing the implant and 4 revisions in the VSB group. Our chart review shows that there also was a similar proportion of revision operations among the patients who did not send back a completely filled questionnaire. Despite these above-described device problems, middle ear implants have been shown to be a cost-effective solution for patients with SNHL (18).
The above-described audiologic gains are measured in the audiologic booth, but the results in daily life use are less rewarding, as some of our patients described. We see that there remained some sound problems despite optimal device fitting. Resonance was mostly seen with the Carina group, maybe because the microphone of this totally implantable device is placed under the skin and reflects the patients_ bodily sounds more than the semiimplantable implants. Feedback was mostly seen in the semi-implantable Otologics group. This implant is the most powerful of the 3 (13) and is used in more severe cases of SNHL, and thus the higher sound amplification required, seen in Figure 6 , might lead to more feedback. All these factors, in addition to the better baseline hearing threshold of the VSB population over the low and mid frequencies (Fig. 2) , might play a role behind the higher satisfaction seen with the VSB (Figs. 7 and 8) , despite the lower SRT gain with this implant. In addition, we have to keep in mind the possible role of other factors inherent in the technology of each device and especially the nature of the coupling to the ossicular chain, namely crimping to the incus long process versus laser hole abutting against the body of the incus. These factors play an important role in the efficiency of the hearing amplification (19) .
The comparison with the conventional hearing aids that the patients wore contralaterally shows that the competition is far from being settled between implants and conventional hearing aids (Fig. 7) . Many authors have found similar subjective assessments of benefit for the digital hearing aid and Otologics implants as measured by the APHAB or other questionnaires (4). Sterkers et al. (10) found 83% patient satisfaction with the VSB, which is close to the 72% satisfaction that our VSB patients reported. However, in many other studies, this satisfaction was not better than with the hearing aids (9, 20) , if not worse (14) . Indeed, we see that many of our patients preferred the contralateral hearing aid over the implant (Fig. 7) , knowing that their baseline hearing loss is symmetrical and thus is not a factor in this preference (Fig. 3) . It is important to note that one factor behind the difference in satisfaction between one implant and another might be a better baseline hearing such as with the VSB and thus a better satisfaction, compared with a poorer baseline such as with the other 2 implants and thus a less rewarding satisfaction. Furthermore, as seen in other studies (9, 11, 13, 14) , the Carina implant is not as powerful as the semi-implantable Otologics implant, and thus poor patient selection also might have played a role in the lower satisfaction seen with the Carina (Fig. 7) where indications might have been pushed beyond the capacity of this implant (Fig. 2 ). An overzealous patient selection also might have been the case with the semiimplantable Otologics implant where the strength of this device might have been occasionally overestimated.
All these findings reflect on one hand the fact that these implants are not the magical solution to SNHL, and there is still space for improvement, and on the other hand, the quick and dramatic evolution of the digital hearing aid technology that was able to keep up and even surpass the implantable devices. This was not the case a few years ago, and this is why at one point in time, the same patients who preferred their implants might now prefer their newer up-to-date hearing aids.
With regard to implant use in different conversation settings, our results show that the implants offered good satisfaction in one-to-one conversations, and many previous studies have shown satisfactory benefit of these implants in quiescence (7, 12) . However, patient satisfaction quickly dropped in crowded situations with more background noise (Fig. 8) , in contradiction to the high patient satisfaction in noise that some previous studies have described (7, 9, 12) . Saliba et al. (8) have shown that the combination of implant/contralateral hearing aid improved functional gain and SRT in quiet, but it did not show any advantage in noise. We think that good amplification in noise remains a challenge for these devices. Therefore, more developments in this technology are needed to better adapt it to the various daily life situations. Another important bonus would be to adapt these implants to magnetic resonance imaging use (21) .
Finally, the choice of the implant to use depends primarily on the degree of hearing loss severity (13) and secondarily on patient expectations in light of the results seen in our study. New algorithms are now being tested to improve on signal processing, as well as to improve coupling of the implants to the ossicular chain. These are promising research protocols that we hope would lead to more patient satisfaction in the future. In addition, the benefits of these implants in cases of SNHL offer a good perspective for patients with mixed hearing loss in which the conventional hearing aids and surgery might fall short of offering good results.
CONCLUSION
Implantable hearing devices offer a reasonable and acceptable alternative for hearing-impaired individuals with SNHL who are unable to benefit from the conventional hearing aids, such as patients with external auditory canal chronic infections or obstructive ostemas. The Bin situ[ audiologic booth results are encouraging and stable on the long term, but the audiologic gains do not correlate with the index of satisfaction of the patients. Therefore, these implants have to be further improved to offer more patient satisfaction in real-life situations and especially in noisy environments and for multimedia use. Proper patient selection is another key point for the success of Copyright @ Otology & Neurotology, Inc. Unauthorized reproduction of this article is prohibited. 
